DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	VGLL3; FOXE1; INHBA; WT1; HOXA6; HOXA11; HOXA13; HOXC12; HOXD11; HOXD12; IRX4; EVX2; LBX2; ATOH7; ISL2; DMRTA2; PITX2; VGLL1; FOXA2; DLX2; FOXD3; EGR4; EMX2; SP9; FOXC2; ZIC5; FOXL2; SP8; ZIC2; DLX6; FOXI3; ASCL5; DUX4L9; EN1; MYT1; EN2; BATF3; FOXL1; TCF15; NR2E1; FOXD1; FOSL1; RXRG; FOXQ1; VAX1; DLX5; DLX1; VAX2;	GO:0006357~regulation of transcription by RNA polymerase II	48	747	6.42570281124498	0	0	0	0	0	0	0
down	LCE6A; LCE2B; KRT34; KRT75; KRT16; KRTAP2-3; CDH3; CASP14; KRT76; DSG2; LCE3E; LCE1C; LCE1D; LCE1E; LCE1F; LCE1B; LCE3A; LCE2A; LCE2C; LCE2D; KRT27; DSG4; KRTAP19-1; PKP2; KRTAP4-1; KRTAP3-1; KRT84; KRT82;	GO:0031424~keratinization	28	181	15.4696132596685	0	0	0	0	0	0	0
down	KRT34; KRT75; KRT16; CASP14; SPRR2B; KRT76; DSG2; LCE1A; LIPN; LIPM; SPINK6; RPTN; KRT27; DSG4; PKP2; LCE3D; SPRR2G; KRT84; KRT82; KLK5;	GO:0070268~cornification	20	113	17.6991150442478	0	0	0	0	0	0	0
down	ST8SIA3; ST8SIA6; B4GALNT1; ST6GALNAC5;	GO:0001574~ganglioside biosynthetic process	4	11	36.3636363636364	0.00010035143442865	0.00507109248646153	0.223783698775908	0.228199161890769	0.208128875005037	0.223783698775908	0.0421242021752016
down	GBX2; PRRX1; FOXG1; DLX5; DLX6; SIX1; SIX4;	GO:0042472~inner ear morphogenesis	7	57	12.280701754386	0.00011245300081075	0.00544081114560961	0.250657738807168	0.255718123843652	0.225043757863507	0.250545285806357	0.0451953556963564
down	GLI2; TNC; MSX1; DLX1; DLX2; AMTN; EDAR;	GO:0042475~odontogenesis of dentin-containing tooth	7	57	12.280701754386	0.00011245300081075	0.00544081114560961	0.250657738807168	0.255718123843652	0.225043757863507	0.250545285806357	0.0451953556963564
down	NKX2-8; RBP4; GLI2; ITGA3; LOX; NKX2-1; TBX4; LHX3;	GO:0030324~lung development	8	80	10	0.00013816612535533	0.00654562018870887	0.307695961166325	0.314189769058026	0.256850827035563	0.307695961166325	0.0543727074446733
down	WT1; HOXA11; HOXD11; LHX1; SIX1; ADAMTS16;	GO:0001658~branching involved in ureteric bud morphogenesis	6	42	14.2857142857143	0.00016510569467587	0.00744558426140681	0.367525276348489	0.375450349692931	0.287779225820043	0.367525276348489	0.0618484670862015
down	HOXD9; HOXD10; HOXA10; HOXA11; FOXL2; DEFB126; FETUB;	GO:0007338~single fertilization	7	61	11.4754098360656	0.00016541511638457	0.00744558426140681	0.36804863395567	0.376153974658514	0.288153132741922	0.36804863395567	0.0618484670862015
down	GATA4; ISL1; TGFB2; SEMA3C;	GO:0003215~cardiac right ventricle morphogenesis	4	13	30.7692307692308	0.00017025962251238	0.00744558426140681	0.378657400467535	0.387170381593154	0.293294039115046	0.378487140845023	0.0618484670862015
down	PAX7; LHX1; LHX5; LHX3;	GO:0021527~spinal cord association neuron differentiation	4	13	30.7692307692308	0.00017025962251238	0.00744558426140681	0.378657400467535	0.387170381593154	0.293294039115046	0.378487140845023	0.0618484670862015
down	GLI2; MSX1; NKX2-1; ISL1; LHX3;	GO:0021983~pituitary gland development	5	27	18.5185185185185	0.00019997207324662	0.00842104619560782	0.444137974680751	0.454736494562822	0.323754786586284	0.444137974680751	0.0699513671694078
down	KITLG; GBX2; ISL1; ALX1; SEMA3A; SEMA3C;	GO:0001755~neural crest cell migration	6	44	13.6363636363636	0.00020768641784785	0.00858688934883665	0.461063847622232	0.472278914186016	0.331259836467324	0.461063847622232	0.0713289816646345
down	NKX2-1; DLX1; DLX2; CDK5R2; FEZ1; LHX5; HSD3B1;	GO:0021766~hippocampus development	7	64	10.9375	0.00021708509525542	0.00866055274755835	0.481494741276522	0.493651506610826	0.340389429360499	0.481494741276522	0.0719408837170915
down	FOXE1; GLI2; TGFB2; KRT27; FOXQ1;	GO:0031069~hair follicle morphogenesis	5	28	17.8571428571429	0.00023237153271282	0.00890547792935061	0.515167688024338	0.528412865388969	0.3550637019852	0.515167688024338	0.0739754113663426
down	PITX3; IGF2; PAX3; LHX1; PDX1; LHX3; LAMC2; LAMB3; LAMA3;	GO:0009887~animal organ morphogenesis	9	111	8.10810810810811	0.00023497303243669	0.00890547792935061	0.520700239879709	0.534328675761037	0.357454666130519	0.520465266847272	0.0739754113663426
down	NTRK1; MDK; ITGA3; CNTN1; PRKD1; NTRK2; PLPPR5; FEZ1; TENM3;	GO:0010976~positive regulation of neuron projection development	9	111	8.10810810810811	0.00023497303243669	0.00890547792935061	0.520700239879709	0.534328675761037	0.357454666130519	0.520465266847272	0.0739754113663426
up	F2; JCHAIN; IGKV1-17; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHA2; IGKV1-16; IGKV3-11; ATP1B1; IGKV2-30; IGKV4-1; IGHV4-34; CEACAM5; CD48; IGLC2; IGLC3; PSG1; VPREB1; SELE; SDC1; IGHV1-2; CEACAM8; CEACAM3; IGLV3-21; ANGPT1; NKX2-3; FCAMR; FOXJ1; SIRPG; CD84;	GO:0050900~leukocyte migration	54	193	27.979274611399	0.00025266985966732	0.104883258747905	1	1	1	1	0.934346286890238
down	MMP1; ELANE; MMP3; MMP10; MMP13; CTRB2; KLK5;	GO:0022617~extracellular matrix disassembly	7	66	10.6060606060606	0.0002582327127627	0.00947130949713542	0.571468993343871	0.587221188822396	0.377708344855232	0.571468993343871	0.0786756221043861
down	SEMA3A; SIX1; SIX4;	GO:0061551~trigeminal ganglion development	3	5	60	0.00026287025531546	0.00948836445376761	0.581469004757801	0.59776696058736	0.380636129696788	0.581469004757801	0.0788172930447568
down	MSX1; MMP13; HAS2; PAPPA2; RARB;	GO:0060349~bone morphogenesis	5	30	16.6666666666667	0.0003089826314172	0.0109785391225427	0.68316059806345	0.702626503842734	0.40971096925922	0.68316059806345	0.0911957734592696
down	HOXB8; HOXD9; HOXD10; EN1; DMBX1; FOXA2;	GO:0008344~adult locomotory behavior	6	48	12.5	0.00031854426952859	0.0111441487524313	0.703982835658201	0.724369668908031	0.415381727465292	0.703982835658201	0.0925714481388794
down	GLI2; RARB; TGFB2; FOXF2;	GO:0048566~embryonic digestive tract development	4	16	25	0.00033271356095121	0.0112923975761651	0.734964256141233	0.756590637603062	0.423064236200699	0.734631542580281	0.0938029112683476
down	ISL1; SIX1; DMRTA2; ISL2;	GO:0048665~neuron fate specification	4	16	25	0.00033271356095121	0.0112923975761651	0.734964256141233	0.756590637603062	0.423064236200699	0.734631542580281	0.0938029112683476
down	HOXD9; HOXD10; CAV1; SIX1; SIX4; POPDC3;	GO:0007519~skeletal muscle tissue development	6	50	12	0.00038902851080446	0.012821026573469	0.858196894834656	0.88465083356936	0.4528291865764	0.858196894834656	0.106500821453424
down	PRRX1; DLX2; SIX1; SIX2; SIX4;	GO:0048701~embryonic cranial skeleton morphogenesis	5	32	15.625	0.00040333036435968	0.0131024749793419	0.889343453413113	0.917173248553932	0.460120145849239	0.889343453413113	0.108838737707669
down	HOXD9; MSX1; HOXA11; EN1; ALX4;	GO:0035115~embryonic forelimb morphogenesis	5	33	15.1515151515152	0.00045793287065332	0.0144630464981341	1	1	0.487618000443445	0.99593937281502	0.120140639592605
down	BMPR1B; DLX1; DLX5; SFRP1; GATA5;	GO:0071773~cellular response to BMP stimulus	5	33	15.1515151515152	0.00045793287065332	0.0144630464981341	1	1	0.487618000443445	0.99593937281502	0.120140639592605
down	LHX2; DLX2; SEMA3A; NR2E1;	GO:0021772~olfactory bulb development	4	18	22.2222222222222	0.00048884376786162	0.0152278181933881	1	1	0.500695261811658	0.99593937281502	0.126493392494422
down	TGFB2; SIX1; SIX4;	GO:0048699~generation of neurons	3	7	42.8571428571429	0.00054902582263538	0.0166464629423049	1	1	0.526515763907334	0.99593937281502	0.138277693091917
down	DLX2; DLX5; DLX1; DLX6;	GO:0009790~embryo development	4	19	21.0526315789474	0.00058376650495173	0.0173868973211402	1	1	0.541151550090256	0.99593937281502	0.144428282448115
down	NTRK1; GLI2; RARB; MIF; DPEP1; WT1; AZU1; PAX7; MT3; MSX1; FLT4; HMGA2; ACTC1; SFRP1; IL31RA; BIRC7; FAIM2; LHX3; SIX4; NR2E1;	GO:0043066~negative regulation of apoptotic process	20	489	4.08997955010225	0.00060158461782555	0.0175385053966066	1	1	0.548763615120663	0.99593937281502	0.145687649978759
up	COLEC12; IGHV3-11; IGHV4-39; IGHV3-74; IGHG2; IGHV3-30; IGHV1-2; TRDC; IGHV1-46; TRBC2; IGHA2; IGHV1-3; IGHV1-18; IGHG4; IGHV3-15; IGHV3-20; IGHV3-21; IGLC3; IGHV3-23; IGHG3; IGHV3-7; IGHV2-5; IGHD; TRBC1; IGHV5-51; IGHV3-73; IGLC2; IGKC; IGHV3-48; IGHV4-59; IGHV4-34; IGHV3-33;	GO:0006910~phagocytosis, recognition	32	99	32.3232323232323	0.00060928172363827	0.229920766802045	1	1	1	1	1
down	HOXC11; GLI2; HOXA11; HOXD12; HOXD13; ALX4;	GO:0042733~embryonic digit morphogenesis	6	55	10.9090909090909	0.00061889557763716	0.0178147916904674	1	1	0.555914040990798	0.99593937281502	0.147982685956095
down	FOXE1; ZIC2; WT1; MT3; NKX2-1; LHX1; HMGA2; FOXG1; FOXL2; FOXF2; FOXD1; IFNL1; SFRP1; ESX1; DMBX1; HMX1; SIX4; SIX2; ZNF488; SIX1; ALX1;	GO:0045892~negative regulation of transcription, DNA-templated	21	530	3.9622641509434	0.00065755642832443	0.0186910414751221	1	1	0.570320130954187	0.99593937281502	0.155261457381249
down	CLDN1; DLX1; CAV1; POSTN; SFRP1; PPARGC1A;	GO:0071560~cellular response to transforming growth factor beta stimulus	6	56	10.7142857142857	0.00067538099071362	0.0189606959615159	1	1	0.576805466118008	0.99593937281502	0.157501404716587
down	MSX1; PRRX1; SIX1; SIX2;	GO:0042474~middle ear morphogenesis	4	20	20	0.00069106491902071	0.0191644100713793	1	1	0.582570325181037	0.99593937281502	0.159193603068863
down	KCNK2; FOSL1; TNC; GATA4; POSTN; SOST;	GO:0009612~response to mechanical stimulus	6	57	10.5263157894737	0.00073577417436054	0.0201584394276613	1	1	0.599131663060031	0.99593937281502	0.167450737736373
down	WT1; SIX1; SIX4;	GO:0072075~metanephric mesenchyme development	3	8	37.5	0.00074530123681804	0.020176369196717	1	1	0.602830707962471	0.99593937281502	0.167599675508396
down	KCNQ1; KCNJ2; CAV1; DSG2; PKP2;	GO:0086091~regulation of heart rate by cardiac conduction	5	38	13.1578947368421	0.00081844728873337	0.0218958721715257	1	1	0.622682250419147	0.99593937281502	0.181883124517673
down	REG1A; ALOX15; CDH3; TNC; LOX; EPPK1; TGFB2;	GO:0042060~wound healing	7	82	8.53658536585366	0.00086289517310556	0.0228165537632796	1	1	0.633365057059481	0.99593937281502	0.189530979021129
up	UGT1A9; UGT1A1; UGT1A3; UGT2B28; UGT1A7; UGT1A8; UGT1A10; UGT1A6;	GO:0052697~xenobiotic glucuronidation	8	9	88.8888888888889	0.00089731380946012	0.271675558593446	1	1	1	1	1
up	MS4A1; CD19; CTLA4; MNDA; NCKAP1L; IGHV4-34; IGHV3-33; IGHV3-11; IGHV3-21; IGHV4-39; IGHV1-2; IGHV2-5; IGLC3; IGHV3-30; TRBC2; IGHV5-51; CD79B; IGHG2; IGHV3-23; IGHV1-3; IGHV3-73; IGHG4; IGHV1-46; IGHV4-59; IGHG3; IGHV1-18; TRBC1; IGHA2; IGHV3-74; IGHV3-20; TRDC; IGHD; IGHV3-15; IGHV3-48; IGLC2; IGHV3-7; IGKC;	GO:0050853~B cell receptor signaling pathway	37	125	29.6	0.00094704840488357	0.271675558593446	1	1	1	1	1
up	IGHG3; IGHG4; IGLC3; IGHV3-15; IGHV4-39; IGHV3-21; IGHD; IGHV4-59; IGHV3-73; IGHV3-23; IGHV1-2; TRBC1; IGHV1-18; IGHV3-74; IGHV3-48; IGHV3-11; TRBC2; IGHG2; IGHV3-33; IGLC2; IGHV3-20; IGHV1-46; IGHV5-51; IGHV1-3; IGHV4-34; IGHV3-7; IGHA2; TRDC; IGKC; IGHV3-30; IGHV2-5;	GO:0050871~positive regulation of B cell activation	31	98	31.6326530612245	0.00098172329050871	0.271675558593446	1	1	1	1	1
down	DSCAM; LHX1; SDK1; FJX1;	GO:0010842~retina layer formation	4	23	17.3913043478261	0.00109582951025189	0.0283172307535545	1	1	0.687105508426191	0.99593937281502	0.235223624197179
up	UGT1A9; UGT1A1; UGT1A3; UGT1A7; UGT1A8; UGT1A6; UGT1A10;	GO:0052696~flavonoid glucuronidation	7	7	100	0.00122094143366369	0.316757993196124	1	1	1	1	1
down	HOXC11; HOXA11; SIX1;	GO:0001759~organ induction	3	10	30	0.00125921934324003	0.03217376164638	1	1	0.720273464333295	0.99593937281502	0.267258789688244
up	FCGR2B; AIF1; DOCK1; IGHG2; IGHV1-2; IGHV3-33; IGHV3-30; IGLC2; IGHV3-7; IGHA2; IGHV3-20; IGHV3-74; IGHV3-21; IGHV2-5; TRDC; TRBC2; IGHV3-11; IGHV4-39; IGHV1-3; IGHV1-46; IGHV4-59; IGHV3-73; IGHV3-15; IGHG3; IGHV3-48; IGKC; IGHV4-34; IGLC3; IGHV5-51; IGHG4; IGHV1-18; IGHD; TRBC1; IGHV3-23;	GO:0006911~phagocytosis, engulfment	34	115	29.5652173913043	0.00150818513902029	0.368263324239602	1	1	1	1	1
down	NPR1; AZU1; HRH1;	GO:0043114~regulation of vascular permeability	3	11	27.2727272727273	0.0015822964308505	0.03787517982899	1	1	0.78036077606783	0.99593937281502	0.314618937989782
down	INHBA; ITGA3; HMGA2;	GO:0048333~mesodermal cell differentiation	3	11	27.2727272727273	0.0015822964308505	0.03787517982899	1	1	0.78036077606783	0.99593937281502	0.314618937989782
down	ELANE; TGFB2; IFNL1;	GO:0050778~positive regulation of immune response	3	11	27.2727272727273	0.0015822964308505	0.03787517982899	1	1	0.78036077606783	0.99593937281502	0.314618937989782
down	INHBA; EPHA8; PPARGC1A;	GO:0071372~cellular response to follicle-stimulating hormone stimulus	3	11	27.2727272727273	0.0015822964308505	0.03787517982899	1	1	0.78036077606783	0.99593937281502	0.314618937989782
down	CAV1; DSG2; PKP2;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	3	11	27.2727272727273	0.0015822964308505	0.03787517982899	1	1	0.78036077606783	0.99593937281502	0.314618937989782
down	IGF2; IL5; MIF; LIF; IL11; KITLG; CNTN1;	GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation	7	92	7.60869565217391	0.00161008217254011	0.0379220294992762	1	1	0.784250618226975	0.99593937281502	0.315008105607657
down	KRT76; EN1; EDAR; TYRP1;	GO:0043473~pigmentation	4	26	15.3846153846154	0.00164302837653985	0.0379220294992762	1	1	0.788653620739126	0.99593937281502	0.315008105607657
down	CYP26A1; RBP4; TRIML2; RXRG; RARB;	GO:0032526~response to retinoic acid	5	46	10.8695652173913	0.00178492869001845	0.039028152318288	1	1	0.804690330211654	0.99593937281502	0.324196370539336
down	DLX1; HTRA3; RBPMS2; SFRP1; SOST;	GO:0030514~negative regulation of BMP signaling pathway	5	47	10.6382978723404	0.00194731722829078	0.0403693437659806	1	1	0.822464063413498	0.99593937281502	0.335337287383011
down	SOX1; PITX3; SOX11;	GO:0002089~lens morphogenesis in camera-type eye	3	12	25	0.00195278267997268	0.0403693437659806	1	1	0.823158030947791	0.99593937281502	0.335337287383011
down	LHX1; FAIM2; LHX5;	GO:0021702~cerebellar Purkinje cell differentiation	3	12	25	0.00195278267997268	0.0403693437659806	1	1	0.823158030947791	0.99593937281502	0.335337287383011
down	EMX2; ARX; LHX5;	GO:0021846~cell proliferation in forebrain	3	12	25	0.00195278267997268	0.0403693437659806	1	1	0.823158030947791	0.99593937281502	0.335337287383011
down	LAMB3; LAMC2; LAMA3;	GO:0031581~hemidesmosome assembly	3	12	25	0.00195278267997268	0.0403693437659806	1	1	0.823158030947791	0.99593937281502	0.335337287383011
down	SOX11; HMGA2; NR2E1;	GO:2000648~positive regulation of stem cell proliferation	3	12	25	0.00195278267997268	0.0403693437659806	1	1	0.823158030947791	0.99593937281502	0.335337287383011
down	RARB; ISL1; TGFB2; SEMA3C;	GO:0003148~outflow tract septum morphogenesis	4	28	14.2857142857143	0.00209838944997887	0.042227766453557	1	1	0.839355779991546	0.99593937281502	0.350774705104626
down	INHBA; HMGA2; LAMB3; LAMA3;	GO:0035987~endodermal cell differentiation	4	28	14.2857142857143	0.00209838944997887	0.042227766453557	1	1	0.839355779991546	0.99593937281502	0.350774705104626
down	GABRD; SLC26A4; GABRA1; CLDN17; ANO4; ANO1; SLC26A10;	GO:1902476~chloride transmembrane transport	7	97	7.21649484536082	0.00213546807916387	0.0425969685264793	1	1	0.843509891269729	0.99593937281502	0.353841567482862
down	PITX3; EN2; MSX1; EN1;	GO:0030901~midbrain development	4	29	13.7931034482759	0.0023557712316824	0.0453455895373252	1	1	0.867636508262037	0.99593937281502	0.376673623390537
down	MDK; CDH3; HAS2;	GO:0010838~positive regulation of keratinocyte proliferation	3	13	23.0769230769231	0.00237296620709837	0.0453455895373252	1	1	0.869675542230895	0.99593937281502	0.376673623390537
down	BMPR1B; TBX4; EVX2;	GO:0035108~limb morphogenesis	3	13	23.0769230769231	0.00237296620709837	0.0453455895373252	1	1	0.869675542230895	0.99593937281502	0.376673623390537
down	GATA4; ISL1; TGFB2;	GO:0060413~atrial septum morphogenesis	3	13	23.0769230769231	0.00237296620709837	0.0453455895373252	1	1	0.869675542230895	0.99593937281502	0.376673623390537
down	MSX1; SOX11; LHX2;	GO:2000678~negative regulation of transcription regulatory region DNA binding	3	13	23.0769230769231	0.00237296620709837	0.0453455895373252	1	1	0.869675542230895	0.99593937281502	0.376673623390537
down	NR2E1; SIX1; SIX4; SIX2; RXRG;	GO:0048856~anatomical structure development	5	50	10	0.00249925126801609	0.0465429683909263	1	1	0.883747393941901	0.99593937281502	0.386619927671924
down	CACNG3; GNGT1; CAV1; MGAT3; TNS4; CCDC68;	GO:0008104~protein localization	6	74	8.10810810810811	0.0025479153764516	0.0465429683909263	1	1	0.88922246638161	0.99593937281502	0.386619927671924
down	LHX2; TCF15; FOXC2; HES7;	GO:0007498~mesoderm development	4	30	13.3333333333333	0.00263405922859616	0.0465429683909263	1	1	0.898214196951292	0.99593937281502	0.386619927671924
down	LHX1; LHX3; LAMC2; SEMA3A;	GO:0008045~motor neuron axon guidance	4	30	13.3333333333333	0.00263405922859616	0.0465429683909263	1	1	0.898214196951292	0.99593937281502	0.386619927671924
down	ADRA2C; HRH1; CAV1; ADRA1B;	GO:0045907~positive regulation of vasoconstriction	4	30	13.3333333333333	0.00263405922859616	0.0465429683909263	1	1	0.898214196951292	0.99593937281502	0.386619927671924
down	LIF; MSX1; HMGA2; PDX1;	GO:0048863~stem cell differentiation	4	30	13.3333333333333	0.00263405922859616	0.0465429683909263	1	1	0.898214196951292	0.99593937281502	0.386619927671924
up	CCR2; CXCR3; CCR5; CCR6; CCR8; CX3CL1; GPR17; ACKR1; CCL23; CCL2; CCL16; CCL21; CCL11; CCL13; CCL1; CCL14; TFF2; XCL2; CXCL13; CCL8; CCL17; CCL18; CCL19;	GO:0070098~chemokine-mediated signaling pathway	23	70	32.8571428571429	0.00280996536127698	0.613903484982144	1	1	1	1	1
down	GATA4; NTRK2; NTRK1;	GO:0051896~regulation of protein kinase B signaling	3	14	21.4285714285714	0.00284497476092294	0.0465429683909263	1	1	0.909730083360834	0.99593937281502	0.386619927671924
down	GLI2; HOXD12; LHX1; SIX1;	GO:0007389~pattern specification process	4	31	12.9032258064516	0.00293406911209693	0.0476576654350601	1	1	0.913967419300442	0.99593937281502	0.39587941638694
down	OOEP; MPPED1; PRB2; CRYBA2; DIO3; EVX2; WT1-AS; ACTBL2; C5orf46; C6orf15; IGFL3; PTCHD4; KNDC1; ASCL5; KRT27; MAGEB6; POPDC3; KRT82; SPANXC; FETUB; INSL5;	GO:0008150~biological_process	21	603	3.48258706467662	0.00295989900291627	0.0477362434938411	1	1	0.915067340794344	0.99593937281502	0.396532143199449
down	CCL24; VGF; PLAU; GAST; REG1A; CGB7; RARB; MDK; GRIA2; GNG10; MAPK10; GNGT1; TNFAIP6; IL1RL1; INSL4; PRKD1; ARTN; CD200R1; CASKIN1; DPYSL5; RETNLB; FGF21; TENM2; TENM3; CCL26; GABRD; PLPPR5; NPR1; SCUBE2; GABRA1;	GO:0007165~signal transduction	30	989	3.03336703741153	0.00334454541645968	0.0528631556804527	1	1	0.933851714359038	0.99593937281502	0.43912002461946
down	ALOX15; CYGB; PPARGC1A;	GO:0019395~fatty acid oxidation	3	15	20	0.00337078169466387	0.0528631556804527	1	1	0.935278998638626	0.99593937281502	0.43912002461946
down	LIF; TGFB2; FOXC2;	GO:0033630~positive regulation of cell adhesion mediated by integrin	3	15	20	0.00337078169466387	0.0528631556804527	1	1	0.935278998638626	0.99593937281502	0.43912002461946
down	NTRK1; SOX11; SEMA3A;	GO:0048485~sympathetic nervous system development	3	15	20	0.00337078169466387	0.0528631556804527	1	1	0.935278998638626	0.99593937281502	0.43912002461946
down	VGF; GAL; PDX1; MAFA;	GO:0030073~insulin secretion	4	33	12.1212121212121	0.00360245590940411	0.055727787333231	1	1	0.941585348820818	0.99593937281502	0.462915749746002
down	HOXD8; HOXC8; TBX4; TCF15;	GO:0048705~skeletal system morphogenesis	4	33	12.1212121212121	0.00360245590940411	0.055727787333231	1	1	0.941585348820818	0.99593937281502	0.462915749746002
down	GLI2; RARB; ADRA2C; SOX11; FOXG1; GDF6;	GO:0045666~positive regulation of neuron differentiation	6	81	7.40740740740741	0.00387313832254566	0.0571524453036041	1	1	0.948918889023685	0.99593937281502	0.47475000055778
down	SOX1; ITGA3; NKX2-1; CDK5R2; SEMA3A; NTRK2; VAX1;	GO:0001764~neuron migration	7	109	6.42201834862385	0.00393426900894633	0.0571524453036041	1	1	0.950611730648676	0.99593937281502	0.47475000055778
down	ST8SIA3; ST8SIA6; ST6GALNAC5;	GO:0009311~oligosaccharide metabolic process	3	16	18.75	0.00395221176154603	0.0571524453036041	1	1	0.951107338062121	0.99593937281502	0.47475000055778
down	MDK; EMX2; NR2E1;	GO:0021542~dentate gyrus development	3	16	18.75	0.00395221176154603	0.0571524453036041	1	1	0.951107338062121	0.99593937281502	0.47475000055778
down	SYT1; SYT3; RIMS4;	GO:0048791~calcium ion-regulated exocytosis of neurotransmitter	3	16	18.75	0.00395221176154603	0.0571524453036041	1	1	0.951107338062121	0.99593937281502	0.47475000055778
down	DSCAM; VSTM2L; MYPN;	GO:0070593~dendrite self-avoidance	3	16	18.75	0.00395221176154603	0.0571524453036041	1	1	0.951107338062121	0.99593937281502	0.47475000055778
down	MMP3; DPEP1; MT3;	GO:0071732~cellular response to nitric oxide	3	16	18.75	0.00395221176154603	0.0571524453036041	1	1	0.951107338062121	0.99593937281502	0.47475000055778
down	PRODH; KCNK2; MT3; PDX1;	GO:0010942~positive regulation of cell death	4	34	11.7647058823529	0.00397239979639785	0.0571524453036041	1	1	0.951607599066303	0.99593937281502	0.47475000055778
down	MSX1; SOX11; GATA4; FOXD1;	GO:0030513~positive regulation of BMP signaling pathway	4	34	11.7647058823529	0.00397239979639785	0.0571524453036041	1	1	0.951607599066303	0.99593937281502	0.47475000055778
down	CHP2; ALOX15; DPEP1; SYT1; LCE1D; SYT3;	GO:0071277~cellular response to calcium ion	6	82	7.31707317073171	0.00409750528982511	0.0571524453036041	1	1	0.954718732529251	0.99593937281502	0.47475000055778
down	FOSL1; FOXG1; TGFB2; NR2E1;	GO:0045787~positive regulation of cell cycle	4	35	11.4285714285714	0.00436719764970406	0.0591131396156371	1	1	0.962092450834366	0.99593937281502	0.49103696117314
down	CPA1; ALOX15; DPEP1;	GO:0006691~leukotriene metabolic process	3	17	17.6470588235294	0.00459094673808602	0.0617740407243054	1	1	0.968480532718226	0.99593937281502	0.513140351432539
down	BMPR1B; DLX1; ISL1; DLX2;	GO:0045597~positive regulation of cell differentiation	4	36	11.1111111111111	0.00478759516571359	0.0640411259225453	1	1	0.972589027051925	0.99593937281502	0.531972418781738
down	DPEP1; MT3; CERS1; KCNQ1; FGF21;	GO:0035690~cellular response to drug	5	59	8.47457627118644	0.00483057148074206	0.0642381260070611	1	1	0.973521817039507	0.99593937281502	0.533608845530182
down	NKX2-8; EPPK1; ISL1; TGFB2; SFRP1;	GO:0050680~negative regulation of epithelial cell proliferation	5	60	8.33333333333333	0.00516070163572657	0.0668117734482167	1	1	0.979574105563584	0.99593937281502	0.554987443027341
down	PACSIN1; SYT1; ACTL8; ACTBL2;	GO:0048488~synaptic vesicle endocytosis	4	37	10.8108108108108	0.00523432148374592	0.0668117734482167	1	1	0.980665890944398	0.99593937281502	0.554987443027341
down	GLI2; EN2; GBX2;	GO:0030902~hindbrain development	3	18	16.6666666666667	0.00528853087980607	0.0668117734482167	1	1	0.981783671215231	0.99593937281502	0.554987443027341
down	BMPR1B; ISL1; ISL2;	GO:0031290~retinal ganglion cell axon guidance	3	18	16.6666666666667	0.00528853087980607	0.0668117734482167	1	1	0.981783671215231	0.99593937281502	0.554987443027341
down	SOX11; RBPMS2; SIX2;	GO:0048557~embryonic digestive tract morphogenesis	3	18	16.6666666666667	0.00528853087980607	0.0668117734482167	1	1	0.981783671215231	0.99593937281502	0.554987443027341
down	RBP4; GATA4; GATA5;	GO:0048738~cardiac muscle tissue development	3	18	16.6666666666667	0.00528853087980607	0.0668117734482167	1	1	0.981783671215231	0.99593937281502	0.554987443027341
down	SYT1; GRIK2; RIMS4;	GO:0050806~positive regulation of synaptic transmission	3	18	16.6666666666667	0.00528853087980607	0.0668117734482167	1	1	0.981783671215231	0.99593937281502	0.554987443027341
down	ISL1; SIX1; SIX4;	GO:0060037~pharyngeal system development	3	18	16.6666666666667	0.00528853087980607	0.0668117734482167	1	1	0.981783671215231	0.99593937281502	0.554987443027341
down	LHX1; SIX1; SIX4;	GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis	3	18	16.6666666666667	0.00528853087980607	0.0668117734482167	1	1	0.981783671215231	0.99593937281502	0.554987443027341
down	CLDN3; KRT16; MIF; DPEP1; NKX2-1; EPPK1; SFRP1;	GO:0030336~negative regulation of cell migration	7	116	6.03448275862069	0.0054126323800886	0.0680018012835441	1	1	0.984101020557203	0.99593937281502	0.564872684375882
down	MIF; LIF; IL11; CAV1; PRKD1; NTRK2;	GO:0033138~positive regulation of peptidyl-serine phosphorylation	6	88	6.81818181818182	0.00565056748001669	0.0684500938170353	1	1	0.988440515503315	0.99593937281502	0.568596529950546
down	VGF; INHBA; KITLG; FOXL2;	GO:0001541~ovarian follicle development	4	38	10.5263157894737	0.00570808848380522	0.0684500938170353	1	1	0.989092234524526	0.99593937281502	0.568596529950546
down	INHBA; MDK; TNC; PDX1; TGFB2;	GO:0009611~response to wounding	5	62	8.06451612903226	0.005868284155085	0.0687859699415634	1	1	0.991784863112161	0.99593937281502	0.571386562633487
down	MDK; SFRP1; SOST;	GO:0030279~negative regulation of ossification	3	19	15.7894736842105	0.00604637621327586	0.0701503036172924	1	1	0.995356717361064	0.99593937281502	0.582719715744829
down	BMPR1B; HOXA11; GDF6;	GO:0032332~positive regulation of chondrocyte differentiation	3	19	15.7894736842105	0.00604637621327586	0.0701503036172924	1	1	0.995356717361064	0.99593937281502	0.582719715744829
down	WT1; LAMB3; LAMC2; LAMA3;	GO:0009888~tissue development	4	39	10.2564102564103	0.00620959014484979	0.0716782131441036	1	1	0.99593937281502	0.99593937281502	0.595411649481916
down	HOXC11; GATA4; NKX2-1;	GO:0007492~endoderm development	3	20	15	0.00686576766951186	0.0783051198845842	1	1	0.99593937281502	0.99593937281502	0.65045958246233
down	GLI2; RARB; PTHLH;	GO:0032331~negative regulation of chondrocyte differentiation	3	20	15	0.00686576766951186	0.0783051198845842	1	1	0.99593937281502	0.99593937281502	0.65045958246233
up	TNFRSF13B; CXCL13; LILRA1; TRPA1; ADGRL2; TSPAN12; F2; IFNG; IL2RA; CD3D; CD3G; CCL2; EDN3; EDN2; EDNRB; LAMA1; KLRC1; CCKBR; ADCYAP1R1; GLP1R; GCGR; SCTR; CXCR3; CCR5; ADGRE1; ADGRF5; LILRB2; CLEC1A; MAGI1; ADGRE3; ADGRL3; CBLC; CLEC4A; TRBV24-1; TRBV19; TRBV6-6; TRBV5-1; CD80; TRBV6-1; TRBV27; TRBV3-1; TRBV2; TRBV28; TRBV6-2; TRBV7-2; TRBV4-1; TRBV29-1; TRBV30; TRBV4-2; TRBV20-1; TRBV6-5; TRBV12-4; TRBV5-6; TRBV23-1; TRBV5-4; TRBV9; TRBV12-3; TRBV18; TRBV7-9; TRBV11-2; TRBV10-3;	GO:0007166~cell surface receptor signaling pathway	61	268	22.7611940298507	0.00711790228244058	1	1	1	1	1	1
down	NKX2-1; MAPK10; HLF; SPSB4; HES7;	GO:0048511~rhythmic process	5	66	7.57575757575758	0.00748331314221495	0.0783051198845842	1	1	0.99593937281502	0.99593937281502	0.65045958246233
down	INHBA; NPR1; WT1; MT3; MSX1; TGFB2; SFRP1;	GO:0030308~negative regulation of cell growth	7	124	5.64516129032258	0.00757243853348588	0.0783051198845842	1	1	0.99593937281502	0.99593937281502	0.65045958246233
down	SOX11; CYP26C1; FOXC2;	GO:0014032~neural crest cell development	3	21	14.2857142857143	0.00774786806245886	0.0783051198845842	1	1	0.99593937281502	0.99593937281502	0.65045958246233
down	CLDN3; CLDN1; CLDN17;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	3	21	14.2857142857143	0.00774786806245886	0.0783051198845842	1	1	0.99593937281502	0.99593937281502	0.65045958246233
down	ITGA3; LOX; SOX11;	GO:0017015~regulation of transforming growth factor beta receptor signaling pathway	3	21	14.2857142857143	0.00774786806245886	0.0783051198845842	1	1	0.99593937281502	0.99593937281502	0.65045958246233
down	CLDN1; TGFB2; SDK1;	GO:0045216~cell-cell junction organization	3	21	14.2857142857143	0.00774786806245886	0.0783051198845842	1	1	0.99593937281502	0.99593937281502	0.65045958246233
down	CACNG3; CACNG4; SHISA9;	GO:2000311~regulation of AMPA receptor activity	3	21	14.2857142857143	0.00774786806245886	0.0783051198845842	1	1	0.99593937281502	0.99593937281502	0.65045958246233
down	CLDN1; POSTN; SFRP1; HAS2; PPARGC1A; CCL26; CCL24;	GO:0071356~cellular response to tumor necrosis factor	7	125	5.6	0.00788144550962355	0.0783205566269457	1	1	0.99593937281502	0.99593937281502	0.650587811331729
down	MDK; ISL1; TGFB2; ALX1;	GO:0010718~positive regulation of epithelial to mesenchymal transition	4	42	9.52380952380952	0.00788716247474519	0.0783205566269457	1	1	0.99593937281502	0.99593937281502	0.650587811331729
down	FOSL1; TGFB2; CAV1; DSG2;	GO:0032570~response to progesterone	4	42	9.52380952380952	0.00788716247474519	0.0783205566269457	1	1	0.99593937281502	0.99593937281502	0.650587811331729
down	WT1; VAX1; PITX2; FOXC2;	GO:0043010~camera-type eye development	4	42	9.52380952380952	0.00788716247474519	0.0783205566269457	1	1	0.99593937281502	0.99593937281502	0.650587811331729
down	WT1; DLX5; DLX6; SIX1; ACTL8;	GO:0030855~epithelial cell differentiation	5	68	7.35294117647059	0.00839666323513444	0.0830174443334596	1	1	0.99593937281502	0.99593937281502	0.689603594986164
down	MMP1; MMP3; MMP10; MMP13;	GO:0030574~collagen catabolic process	4	43	9.30232558139535	0.00850616522354142	0.0837360160966805	1	1	0.99593937281502	0.99593937281502	0.695572577471125
down	FOXE1; NKX2-1; SIX1;	GO:0030878~thyroid gland development	3	22	13.6363636363636	0.00869372291661297	0.0841256421803314	1	1	0.99593937281502	0.99593937281502	0.698809096616509
down	GLI2; HOXD9; CAV1;	GO:0030879~mammary gland development	3	22	13.6363636363636	0.00869372291661297	0.0841256421803314	1	1	0.99593937281502	0.99593937281502	0.698809096616509
down	CACNB4; CAV1; CACNG4;	GO:0051899~membrane depolarization	3	22	13.6363636363636	0.00869372291661297	0.0841256421803314	1	1	0.99593937281502	0.99593937281502	0.698809096616509
down	MDK; LHX2; NR2E1;	GO:2000179~positive regulation of neural precursor cell proliferation	3	22	13.6363636363636	0.00869372291661297	0.0841256421803314	1	1	0.99593937281502	0.99593937281502	0.698809096616509
down	LIF; ISL1; IFNL1; IL31RA; IL20;	GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein	5	69	7.2463768115942	0.00888105378628956	0.0855742216526375	1	1	0.99593937281502	0.99593937281502	0.710842056914744
down	CLDN3; FGF19; IGF2; NTRK1; MT3; FLT4; NTRK2; KNDC1;	GO:0001934~positive regulation of protein phosphorylation	8	161	4.96894409937888	0.0090164945381459	0.0861404570556789	1	1	0.99593937281502	0.99593937281502	0.715545622203712
down	PTHLH; ALOX15; LOX; MMP13;	GO:0030282~bone mineralization	4	44	9.09090909090909	0.0091560854197057	0.0861404570556789	1	1	0.99593937281502	0.99593937281502	0.715545622203712
down	CLDN3; PLAU; REG1A; MT3; TGFB2; CAV1; POSTN; CYGB;	GO:0001666~response to hypoxia	8	163	4.9079754601227	0.0096390900011657	0.0861404570556789	1	1	0.99593937281502	0.99593937281502	0.715545622203712
down	CYP7B1; CYP26A1; CYP26C1;	GO:0016125~sterol metabolic process	3	23	13.0434782608696	0.00970426514806499	0.0861404570556789	1	1	0.99593937281502	0.99593937281502	0.715545622203712
down	GLI2; HOXA11; DMBX1;	GO:0048589~developmental growth	3	23	13.0434782608696	0.00970426514806499	0.0861404570556789	1	1	0.99593937281502	0.99593937281502	0.715545622203712
down	REG1A; SYT1; SYT3;	GO:1903861~positive regulation of dendrite extension	3	23	13.0434782608696	0.00970426514806499	0.0861404570556789	1	1	0.99593937281502	0.99593937281502	0.715545622203712
down	LOX; TGFB2; FOXC2; LOXL4;	GO:0030199~collagen fibril organization	4	45	8.88888888888889	0.00983749919270549	0.0863724832595069	1	1	0.99593937281502	0.99593937281502	0.71747300151026
down	SOX11; HLF; VAX1; DMRTA2;	GO:0035914~skeletal muscle cell differentiation	4	45	8.88888888888889	0.00983749919270549	0.0863724832595069	1	1	0.99593937281502	0.99593937281502	0.71747300151026
up	APOA1; APOE; APOC3; APOA4; LPL; GPIHBP1;	GO:0034371~chylomicron remodeling	6	9	66.6666666666667	0.0105036111968486	1	1	1	1	1	1
up	UGT1A9; UGT1A1; UGT1A7; UGT1A10; UGT1A8;	GO:0051552~flavone metabolic process	5	6	83.3333333333333	0.0105039799827337	1	1	1	1	1	1
down	TCF15; FOXC2; SEMA3C; HES7;	GO:0001756~somitogenesis	4	46	8.69565217391304	0.0105509617474883	0.0919267701677713	1	1	0.99593937281502	0.99593937281502	0.763610969864701
down	KCNQ1; TGFB2; SIX1; LHX3;	GO:0048839~inner ear development	4	46	8.69565217391304	0.0105509617474883	0.0919267701677713	1	1	0.99593937281502	0.99593937281502	0.763610969864701
down	NKX2-1; SFRP1; FOXA2;	GO:0010719~negative regulation of epithelial to mesenchymal transition	3	24	12.5	0.0107803196027193	0.0935665907503194	1	1	0.99593937281502	0.99593937281502	0.777232518660099
down	NTRK2; FLT4; ROS1; EPHA8; NTRK1;	GO:0033674~positive regulation of kinase activity	5	73	6.84931506849315	0.0110114372573453	0.0952091571224459	1	1	0.99593937281502	0.99593937281502	0.790876875991457
down	IGF2; FGF5; MDK; TGFB2;	GO:0051781~positive regulation of cell division	4	47	8.51063829787234	0.0112970071141174	0.0973083112784204	1	1	0.99593937281502	0.99593937281502	0.808313985312428
down	CLDN3; STC2; FGF19; ROS1; MIF; SOX11; TGFB2; SFRP1; GATA5;	GO:0010629~negative regulation of gene expression	9	204	4.41176470588235	0.0117034952486328	0.0984190670828436	1	1	0.99593937281502	0.99593937281502	0.817540735208574
down	ISL1; FOXC2; PKP2;	GO:0055010~ventricular cardiac muscle tissue morphogenesis	3	25	12	0.0119226074556811	0.0984190670828436	1	1	0.99593937281502	0.99593937281502	0.817540735208574
down	CLDN1; KRT16; FLG2;	GO:0061436~establishment of skin barrier	3	25	12	0.0119226074556811	0.0984190670828436	1	1	0.99593937281502	0.99593937281502	0.817540735208574
down	INHBA; GDF6; TGFB2; INHBE;	GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation	4	48	8.33333333333333	0.0120761479379932	0.0984270982472991	1	1	0.99593937281502	0.99593937281502	0.817607447932928
up	CCL11; CCL13; CCL1; CX3CL1; CCL18; CCL23; XCL2; CCL8; CCL2;	GO:0048245~eosinophil chemotaxis	9	20	45	0.0121773595883242	1	1	1	1	1	1
down	CCL24; KRT16; MDK; CTNNA2; KRT76; KRT84; PACSIN1;	GO:0007010~cytoskeleton organization	7	139	5.03597122302158	0.0132436376978644	0.107557257589085	1	1	0.99593937281502	0.99593937281502	0.893449227397995
down	HRH1; JPH3; RIMS4; VGF;	GO:0048167~regulation of synaptic plasticity	4	50	8	0.0137356586181703	0.111156183977648	1	1	0.99593937281502	0.99593937281502	0.923344541516259
down	NKX2-8; CTNNA2; VAX2; ISL2; ISL1;	GO:0007409~axonogenesis	5	78	6.41025641025641	0.0141328362182892	0.112293695935475	1	1	0.99593937281502	0.99593937281502	0.932793547586667
down	LHX1; POSTN; SFRP1;	GO:0044344~cellular response to fibroblast growth factor stimulus	3	27	11.1111111111111	0.0144082751520795	0.112293695935475	1	1	0.99593937281502	0.99593937281502	0.932793547586667
down	SLC26A4; SIX1; ATCAY; SIX4;	GO:0032880~regulation of protein localization	4	51	7.84313725490196	0.0146169454691735	0.112293695935475	1	1	0.99593937281502	0.99593937281502	0.932793547586667
down	EN1; GAD1; NRXN1; NR2E1;	GO:0035176~social behavior	4	51	7.84313725490196	0.0146169454691735	0.112293695935475	1	1	0.99593937281502	0.99593937281502	0.932793547586667
down	PITX3; TGFB2; GRIK2; PCSK9;	GO:0043525~positive regulation of neuron apoptotic process	4	52	7.69230769230769	0.0155331615936026	0.118930671595463	1	1	0.99593937281502	0.99593937281502	0.987925120374902
down	STC2; KCNK2; MT3; GNGT1; SFRP1; PPARGC1A;	GO:0071456~cellular response to hypoxia	6	111	5.40540540540541	0.0156566325568982	0.119404834662124	1	1	0.99593937281502	0.99593937281502	0.991863865514614
down	FLT4; GATA4; ISL1;	GO:0010575~positive regulation of vascular endothelial growth factor production	3	28	10.7142857142857	0.0157526167100428	0.119404834662124	1	1	0.99593937281502	0.99593937281502	0.991863865514614
down	RARB; MSX1; ALX4;	GO:0035116~embryonic hindlimb morphogenesis	3	28	10.7142857142857	0.0157526167100428	0.119404834662124	1	1	0.99593937281502	0.99593937281502	0.991863865514614
down	TFPI; SFRP1; HAS2; CCL26; CCL24;	GO:0071347~cellular response to interleukin-1	5	81	6.17283950617284	0.016264892777007	0.122878292939914	1	1	0.99593937281502	0.99593937281502	1
down	ZIC2; SYT1; MT3; NKX2-1; FOXG1; DLX2; VAX1; DMBX1; EMX2;	GO:0007420~brain development	9	217	4.14746543778802	0.0166245012756339	0.124938155414652	1	1	0.99593937281502	0.99593937281502	1
down	HOXC11; HOXA11; FOXC2;	GO:0001656~metanephros development	3	29	10.3448275862069	0.0171651229783318	0.124938155414652	1	1	0.99593937281502	0.99593937281502	1
down	SCIN; SYT1; SYT3;	GO:0017156~calcium-ion regulated exocytosis	3	29	10.3448275862069	0.0171651229783318	0.124938155414652	1	1	0.99593937281502	0.99593937281502	1
up	PTH; ADRA2A; NOS1; STC1; CAV3; LILRB2; LILRB1;	GO:0051926~negative regulation of calcium ion transport	7	14	50	0.0174404053507093	1	1	1	1	1	1
down	GUCA2B; CTRB2; PPARGC1A;	GO:0007586~digestion	3	30	10	0.0186460581530079	0.134606781714095	1	1	0.99593937281502	0.99593937281502	1
down	BMPR1B; DLX5; GDF6; DSG4; TGFB2;	GO:0030509~BMP signaling pathway	5	85	5.88235294117647	0.0194256716004415	0.139791067150013	1	1	0.99593937281502	0.99593937281502	1
down	BMPR1B; LHX2; VAX2; NR2E1;	GO:0060041~retina development in camera-type eye	4	56	7.14285714285714	0.019555066758286	0.140278302234518	1	1	0.99593937281502	0.99593937281502	1
down	RBP4; PAX7; DLX1;	GO:0048706~embryonic skeletal system development	3	31	9.67741935483871	0.0201956064360436	0.140442841087349	1	1	0.99593937281502	0.99593937281502	1
up	S100A8; S100A9; SELE; CCR6; CX3CL1; FUT7;	GO:0002523~leukocyte migration involved in inflammatory response	6	11	54.5454545454545	0.0204283779809824	1	1	1	1	1	1
down	NKX2-1; PLA2G4E; PCSK9; PLPPR5;	GO:0006644~phospholipid metabolic process	4	57	7.01754385964912	0.0206515487482288	0.142307945010522	1	1	0.99593937281502	0.99593937281502	1
down	CYP7B1; DLX5; DLX6; SFRP1;	GO:0050679~positive regulation of epithelial cell proliferation	4	57	7.01754385964912	0.0206515487482288	0.142307945010522	1	1	0.99593937281502	0.99593937281502	1
up	DEFB4A; CXCL13; HP; S100A8; S100A9; PRG2; IL10; RAG2; IRF8; COLEC12; GBP6; DEFB108B; S100A14; STAB1; SLAMF8; ADAMTS5; IGHV3-48; IGHG2; IGLC3; IGHG3; IGHV1-46; TRBC1; IGHV3-73; IGHV1-2; TRBC2; IGHV3-30; IGHA2; IGLC2; IGHV2-5; IGHD; IGHV3-74; IGHV1-18; IGHV3-7; IGHV4-34; IGHV3-15; IGHV5-51; IGHV3-23; HAMP; TRDC; IGHV3-20; IGKC; IGHV4-39; IGHV3-21; IGHV3-11; IGHV4-59; IGHV1-3; IGHV3-33; IGHG4;	GO:0042742~defense response to bacterium	48	216	22.2222222222222	0.0214322919246021	1	1	1	1	1	1
down	IL31RA; FLT4; NTRK1; EPHA8; NTRK2; ROS1;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	6	120	5	0.0217152582682368	0.147624002483852	1	1	0.99593937281502	0.99593937281502	1
down	MDK; GRIK2; NR2E1;	GO:0001662~behavioral fear response	3	32	9.375	0.0218138755601577	0.147624002483852	1	1	0.99593937281502	0.99593937281502	1
down	LIF; FOXC2; SEMA3C;	GO:0001974~blood vessel remodeling	3	32	9.375	0.0218138755601577	0.147624002483852	1	1	0.99593937281502	0.99593937281502	1
down	FOXG1; ISL1; ISL2; NR2E1;	GO:0045665~negative regulation of neuron differentiation	4	59	6.77966101694915	0.0229558584771237	0.147624002483852	1	1	0.99593937281502	0.99593937281502	1
down	TGFB2; GDF6; INHBE; INHBA;	GO:0060395~SMAD protein signal transduction	4	59	6.77966101694915	0.0229558584771237	0.147624002483852	1	1	0.99593937281502	0.99593937281502	1
down	INHBA; TGFB2; PITX2;	GO:0042476~odontogenesis	3	33	9.09090909090909	0.0235009002020934	0.147624002483852	1	1	0.99593937281502	0.99593937281502	1
down	WT1; CAV1; NTRK2; HAS2;	GO:0001570~vasculogenesis	4	60	6.66666666666667	0.0241642109433047	0.147624002483852	1	1	0.99593937281502	0.99593937281502	1
up	FZD7; WNT5A; MYOC; FZD10;	GO:0038031~non-canonical Wnt signaling pathway via JNK cascade	4	5	80	0.0243597225508831	1	1	1	1	1	1
up	CD1A; CD1C; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	4	5	80	0.0243597225508831	1	1	1	1	1	1
up	TGM5; PPL; KRT33A; KRT37; KRT38; IVL; KRT19; KRT3; KRT13; KRT4; FLG; SPRR1B; SPRR2D; SPRR1A; SPRR2A; KRT6C; TCHH; KRT32; KRT31; KRT24; SPINK9; KRT40; KRT78; KRT35; SPRR2F; SPRR3; KLK12; KLK13;	GO:0070268~cornification	28	113	24.7787610619469	0.0243933867666056	1	1	1	1	1	1
down	MSX1; SIX1; SIX4;	GO:0034504~protein localization to nucleus	3	34	8.82352941176471	0.0252566452866421	0.147624002483852	1	1	0.99593937281502	0.99593937281502	1
down	KCNQ2; KCNK2; KCNQ1; KCNJ2; SLC9A3; KCNF1;	GO:0071805~potassium ion transmembrane transport	6	125	4.8	0.025683778842546	0.147624002483852	1	1	0.99593937281502	0.99593937281502	1
up	IGKV1-17; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGKV1-16; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; IGLC2; IGLC3; FCER1A; IGHV1-2; LILRA4; IGLV3-21; MS4A2;	GO:0038095~Fc-epsilon receptor signaling pathway	39	171	22.8070175438596	0.0259999660915015	1	1	1	1	1	1
down	FOSL1; NTRK2; JPH3; NRXN1;	GO:0007612~learning	4	62	6.45161290322581	0.0266944629708414	0.147624002483852	1	1	0.99593937281502	0.99593937281502	1
down	BMPR1B; RBP4; TGFB2;	GO:0001654~eye development	3	35	8.57142857142857	0.0270810091858837	0.147624002483852	1	1	0.99593937281502	0.99593937281502	1
down	GABRD; GRIA2; GABRA1;	GO:0060078~regulation of postsynaptic membrane potential	3	35	8.57142857142857	0.0270810091858837	0.147624002483852	1	1	0.99593937281502	0.99593937281502	1
down	NUAK1; PLAU; MELTF; HOXD13; BIRC7; ARX; TGFB2;	GO:0042127~regulation of cell population proliferation	7	163	4.29447852760736	0.0278022152057238	0.147624002483852	1	1	0.99593937281502	0.99593937281502	1
down	ELANE; CAV1; GRIK2; STC2; ATP13A5;	GO:0006874~cellular calcium ion homeostasis	5	94	5.31914893617021	0.0279408399865347	0.147624002483852	1	1	0.99593937281502	0.99593937281502	1
up	TYROBP; CTLA4; IL10; FCGR2B; MNDA; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	7	16	43.75	0.0288249409313497	1	1	1	1	1	1
down	GLI2; HMGA2; SIX2;	GO:0002062~chondrocyte differentiation	3	37	8.10810810810811	0.0309348726230969	0.147624002483852	1	1	0.99593937281502	0.99593937281502	1
down	CCL24; GATA4; HMGA2; ISL1; PRKD1; NR2E1;	GO:0045766~positive regulation of angiogenesis	6	131	4.58015267175572	0.0310479225117521	0.147624002483852	1	1	0.99593937281502	0.99593937281502	1
up	APOE; APOA4; LPL; CETP; APOA1;	GO:0034372~very-low-density lipoprotein particle remodeling	5	9	55.5555555555556	0.0320722469119075	1	1	1	1	1	1
down	KRT75; INHBA; SFRP1; ANLN;	GO:0002244~hematopoietic progenitor cell differentiation	4	66	6.06060606060606	0.032214285305214	0.147624002483852	1	1	0.99593937281502	0.99593937281502	1
up	S100A8; S100A9; EDN3; EDN2; NCKAP1L; CCL1; XCL2; CCL8; CX3CL1; CCL21; CCL13; CCL16; CCL14; CCL17; CCL11; CCL18; CCL19; CXCL13; CCL23; CCL2;	GO:0030593~neutrophil chemotaxis	20	76	26.3157894736842	0.032601916506975	1	1	1	1	1	1
down	GRIA2; GRIK2; ANO4; ATP13A5; ANO1; TMC7; GABRA1; GABRD;	GO:0034220~ion transmembrane transport	8	208	3.84615384615385	0.0335875036467251	0.147624002483852	1	1	0.99593937281502	0.99593937281502	1
up	NR1I2; CYP2A6; CYP2C9; NOS1; CYP2C19; CYP2F1; CYP2C18; CYP2A7; CYP2G1P;	GO:0042738~exogenous drug catabolic process	9	25	36	0.0341229174598434	1	1	1	1	1	1
down	CLDN3; CLDN1; RBP4; TNC; ACTC1;	GO:0045471~response to ethanol	5	100	5	0.0347524359673274	0.150814960667371	1	1	0.99593937281502	0.99593937281502	1
up	FMO2; CYP2F1; CYP2C19; CYP2A7; CYP2A6; CYP2C9; CYP2G1P; CYP2C18;	GO:0006082~organic acid metabolic process	8	21	38.0952380952381	0.0354601174006036	1	1	1	1	1	1
up	CYP2C9; CYP2C19; CYP4A11; CYP2G1P; CYP2A7; CYP2F1; CYP2C18; CYP2A6;	GO:0019373~epoxygenase P450 pathway	8	21	38.0952380952381	0.0354601174006036	1	1	1	1	1	1
up	APOA1; IL10; ANGPT1; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	4	6	66.6666666666667	0.0363025463890621	1	1	1	1	1	1
up	CCL21; IGF1; CCL19;	GO:0010560~positive regulation of glycoprotein biosynthetic process	3	3	100	0.0364968486090973	1	1	1	1	1	1
up	PAX6; NKX6-1; NKX6-2;	GO:0021912~regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification	3	3	100	0.0364968486090973	1	1	1	1	1	1
up	AIRE; S100A8; S100A9;	GO:0032602~chemokine production	3	3	100	0.0364968486090973	1	1	1	1	1	1
up	SLIT3; SLIT2; ROBO2;	GO:0061364~apoptotic process involved in luteolysis	3	3	100	0.0364968486090973	1	1	1	1	1	1
up	MYO7B; ANKS4B; USH1C;	GO:1904970~brush border assembly	3	3	100	0.0364968486090973	1	1	1	1	1	1
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.0364968486090973	1	1	1	1	1	1
down	MELTF; ROS1; KAZALD1; PAPPA2;	GO:0001558~regulation of cell growth	4	69	5.79710144927536	0.0367602164294945	0.157420741129123	1	1	0.99593937281502	0.99593937281502	1
down	HMGA2; TGFB2; FOXF2;	GO:0001837~epithelial to mesenchymal transition	3	40	7.5	0.0372242769385649	0.157420741129123	1	1	0.99593937281502	0.99593937281502	1
down	NTRK1; REG1A; FGF21;	GO:0031667~response to nutrient levels	3	40	7.5	0.0372242769385649	0.157420741129123	1	1	0.99593937281502	0.99593937281502	1
down	IGF2; TNC; LOX; DLX5; SFRP1;	GO:0001649~osteoblast differentiation	5	106	4.71698113207547	0.0425074766678861	0.163333285592784	1	1	0.99593937281502	0.99593937281502	1
down	CCL24; FLT4; PRKD1; CCL26;	GO:0001938~positive regulation of endothelial cell proliferation	4	73	5.47945205479452	0.0433663636489495	0.163333285592784	1	1	0.99593937281502	0.99593937281502	1
down	CDH3; PKP2; CDH26;	GO:0007043~cell-cell junction assembly	3	43	6.97674418604651	0.0441144012220336	0.163333285592784	1	1	0.99593937281502	0.99593937281502	1
down	FOXE1; SIX1; SIX4;	GO:0048538~thymus development	3	44	6.81818181818182	0.0465422354946441	0.163333285592784	1	1	0.99593937281502	0.99593937281502	1
down	MDK; CNTN1; FOXC2; HES7; SUSD5;	GO:0007219~Notch signaling pathway	5	109	4.58715596330275	0.046744870165243	0.163333285592784	1	1	0.99593937281502	0.99593937281502	1
down	NKX2-8; PDX1; PCSK9; RARB;	GO:0001889~liver development	4	75	5.33333333333333	0.0469030850588544	0.163333285592784	1	1	0.99593937281502	0.99593937281502	1
down	NTRK1; NTRK2; ATOH7; PPARGC1A;	GO:0007623~circadian rhythm	4	75	5.33333333333333	0.0469030850588544	0.163333285592784	1	1	0.99593937281502	0.99593937281502	1
up	F13A1; IVL; FLG; SPRR1B; SPRR1A; TGM3; TGM6; TGM5; TGM7;	GO:0018149~peptide cross-linking	9	27	33.3333333333333	0.0477943277002697	1	1	1	1	1	1
up	APOA1; APOE; APOC3; LPL; CETP; GCKR; GPIHBP1; ANGPTL4; APOA4;	GO:0070328~triglyceride homeostasis	9	27	33.3333333333333	0.0477943277002697	1	1	1	1	1	1
down	FOXE1; L1CAM; TGFB2; FAT1; MISP; SIX2; LAMB3; LAMA3;	GO:0016477~cell migration	8	225	3.55555555555556	0.0486506275093689	0.163333285592784	1	1	0.99593937281502	0.99593937281502	1
down	ALOX15; KAZALD1; FOXC2; SOST;	GO:0001503~ossification	4	76	5.26315789473684	0.0487297225143775	0.163333285592784	1	1	0.99593937281502	0.99593937281502	1
down	DPEP1; TGFB2; CCL26; CCL24;	GO:0030593~neutrophil chemotaxis	4	76	5.26315789473684	0.0487297225143775	0.163333285592784	1	1	0.99593937281502	0.99593937281502	1
down	NKX2-8; FOSL1; PAX3; HOXD13; LHX1; PDX1; ALX1; HLF; BATF3;	GO:0006366~transcription by RNA polymerase II	9	266	3.38345864661654	0.0488017319615999	0.163333285592784	1	1	0.99593937281502	0.99593937281502	1
down	FBP2; RBP4; PPARGC1A;	GO:0006094~gluconeogenesis	3	45	6.66666666666667	0.0490346454998625	0.163333285592784	1	1	0.99593937281502	0.99593937281502	1
down	DSCAM; MDK; TNC;	GO:0007162~negative regulation of cell adhesion	3	45	6.66666666666667	0.0490346454998625	0.163333285592784	1	1	0.99593937281502	0.99593937281502	1
down	CDH16; CDH26; CDH3;	GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	3	45	6.66666666666667	0.0490346454998625	0.163333285592784	1	1	0.99593937281502	0.99593937281502	1
